Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 7, 2025, after the close
10-Q filed Aug 7, 2025, 38 days after period end · 0000320017-25-000060
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $70.00K | $0.00 | $0.00 | — |
| Net Income | -$4.66M | -$5.04M | -$4.03M | -$6.63M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.54 |
| -$0.61 |
| -$0.50 |
| -$1.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
